ORIGINAL ARTICLES: Epidemiology and Neurobiology of Female Sexual Dysfunction

INTRODUCTION Although several conceptual frameworks for female sexual dysfunction (FSD) have been advanced, there still is considerable disagreement over what constitutes a normal vs. abnormal response. Sexual dysfunction is a disturbance in sexual functioning involving one or multiple phases of the sexual response cycle or pain associated with sexual activity, while a sexual disorder includes both dysfunction and marked distress. AIM Review the literature regarding the epidemiology and neurobiology of FSD. METHODS Review of the literature. RESULTS While a wide range of epidemiologic studies has been published, it is still difficult to determine the scope of FSD and sexual disorders in the general population. It is becoming clear that good sexual health is associated with good physical and mental health as well as compatible relationships with one's sexual partner. Central nervous system (CNS) control of the sexual response is a relatively new area of scientific exploration. CONCLUSIONS We are improving our understanding of the contributions of the CNS neuroendocrine and neurotransmitter systems that modulate sexual behavior.

[1]  D. Lorrain,et al.  Hormone-neurotransmitter interactions in the control of sexual behavior , 1999, Behavioural Brain Research.

[2]  E. Laan,et al.  Assessment and management of women's sexual dysfunctions: problematic desire and arousal. , 2005, The journal of sexual medicine.

[3]  A. Daal,et al.  Melanocortins and their receptors and antagonists. , 2003, Current drug targets.

[4]  I. Goldstein,et al.  Biology of female sexual function. , 2002, The Urologic clinics of North America.

[5]  R. Leadbetter,et al.  Prevalence of sexual dysfunction among newer antidepressants. , 2002, The Journal of clinical psychiatry.

[6]  P. Cleary,et al.  Sexual Dysfunction in Women With Type 1 Diabetes , 2009, Diabetes Care.

[7]  A. Argiolas,et al.  Central oxytocinergic neurotransmission: a drug target for the therapy of psychogenic erectile dysfunction. , 2003, Current drug targets.

[8]  R. Rosen,et al.  Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS) , 2006, Menopause.

[9]  R. Goldberg,et al.  The impact of the overactive bladder syndrome on sexual function: a preliminary report from the Multicenter Assessment of Transdermal Therapy in Overactive Bladder with Oxybutynin trial. , 2006, American journal of obstetrics and gynecology.

[10]  Dan Zhou,et al.  Interactive effects of central leptin and peripheral fuel oxidation on estrous cyclicity. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

[11]  Cushing,et al.  Prior Exposure To Oxytocin Mimics the Effects Of Social Contact and Facilitates Sexual Behaviour In Females , 1999, Journal of neuroendocrinology.

[12]  P. J. Smith,et al.  Sexual dysfunction with antihypertensive and antipsychotic agents. , 1986, Clinical pharmacy.

[13]  J. Schaffir.  Hormonal Contraception and Sexual Desire: A Critical Review , 2006, Journal of sex & marital therapy.

[14]  N. Longo,et al.  Female sexual dysfunction: an update on physiopathology. , 2003, Journal of endocrinological investigation.

[15]  A. Halaris.  Neurochemical Aspects of the Sexual Response Cycle , 2003, CNS Spectrums.

[16]  D. Gath,et al.  Sexual dysfunction among middle aged women in the community , 1988, British medical journal.

[17]  S. Kleeman,et al.  Female Sexual Dysfunction: Principles of Diagnosis and Therapy , 2005, Obstetrical & gynecological survey.

[18]  Virginia E. Johnson,et al.  Human Sexual Response , 1966 .

[19]  Sexual Activity and Function in Middle-Aged and Older Women , 2006, Obstetrics and gynecology.

[20]  K. Mchichi Alami,et al.  Sexual dysfunction in women: population based epidemiological study , 2002, Archives of Women's Mental Health.

[21]  Christopher P Austin,et al.  A role for the melanocortin 4 receptor in sexual function , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[22]  C. Meston,et al.  The sensitivity of event logs, self-administered questionnaires and photoplethysmography to detect treatment-induced changes in female sexual arousal disorder (FSAD) diagnosis. , 2006, The journal of sexual medicine.

[23]  J. Blaustein,et al.  Leptin facilitates and inhibits sexual behavior in female hamsters. , 1997, The American journal of physiology.

[24]  L. Dennerstein,et al.  What can prevalence studies tell us about female sexual difficulty and dysfunction? , 2006, The journal of sexual medicine.

[25]  P. Croft,et al.  Sexual problems: a study of the prevalence and need for health care in the general population. , 1998, Family practice.

[26]  K. Demyttenaere,et al.  Sexual dysfunction in women with type 1 diabetes: a controlled study. , 2002, Diabetes care.

[27]  M. Hogben,et al.  Sexual history-taking among primary care physicians. , 2006, Journal of the National Medical Association.

[28]  L. Heim,et al.  Evaluation and differential diagnosis of dyspareunia. , 2001, American family physician.

[29]  W. Fisher,et al.  Women's endorsement of models of female sexual response: the nurses' sexuality study. , 2007, The journal of sexual medicine.

[30]  F. Montorsi,et al.  Sexual function and endocrine profile in fertile women with type 1 diabetes. , 2006, Diabetes care.

[31]  E. Laumann,et al.  Sexual dysfunction in the United States: prevalence and predictors. , 1999, JAMA.

[32]  G. Bachmann.  Female sexuality and sexual dysfunction: are we stuck on the learning curve? , 2006, The journal of sexual medicine.

[33]  K. Hatzimouratidis,et al.  Predictors of physicians' involvement in addressing sexual health issues. , 2006, The journal of sexual medicine.

[34]  Dan Zhou,et al.  Leptin and Metabolic Control of Reproduction , 2000, Hormones and Behavior.

[35]  S. Koslow,et al.  Somatic symptoms in primary affective disorder. Presence and relationship to the classification of depression. , 1985, Archives of general psychiatry.

[36]  L. Derogatis,et al.  Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. , 2000, The Journal of urology.

[37]  K. Hutchison,et al.  Appetitive Responses to Sexual Stimuli Are Attenuated in Individuals with Low Levels of Sexual Desire , 2005, Archives of sexual behavior.

[38]  J. Warnock.  Female Hypoactive Sexual Desire Disorder , 2002, CNS drugs.

[39]  A. Clayton.  Sexual function and dysfunction in women. , 2003, The Psychiatric clinics of North America.